Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors
US-10988487-B2 · Apr 27, 2021 · US
This page is not indexed by search engines while we improve data quality.
Patent family 61301591
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 61301591 |
| Family type | — |
| Earliest priority | Aug 29, 2016 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US10988487B2 — Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors |
Representative publication
Best representative member for this family based on priority and filing country.
US10988487B2 — Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors (published Apr 27, 2021)
Member publications
Related publications in this family.